Evidence map›Paper›PMID 27416858›Full record

ArticleJournal of neurology2016

Epilepsy and tobacco smoking: a cross-sectional study.

Omar Torriani, Frédéric Vuilleumier, Thomas Perneger, Paul-Andre Despland, Malin Maeder, Anne-Chantal Héritier-Barras, Serge Vulliemoz, Margitta Seeck, Andrea O Rossetti, Fabienne Picard

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of neurology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Article
  3. Alcohol and Disability Sports: Insights from Swiss Coaches.Substance abuse and rehabilitation · 2025
    Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Omar TorrianiDepartment of General Internal Medicine, University Hospital and Medical School of Geneva, Geneva, Switzerland.
Frédéric VuilleumierDepartment of General Internal Medicine, University Hospital and Medical School of Geneva, Geneva, Switzerland.
Thomas PernegerDepartment of Clinical Epidemiology, University Hospital and Medical School of Geneva, Geneva, Switzerland.
Paul-Andre DesplandClinique La Prairie, Clarens, Switzerland.
Malin MaederInstitution de Lavigny, Lavigny, Switzerland.
Anne-Chantal Héritier-BarrasDepartment of Neurology, University Hospitals and Medical School of Geneva, 4 rue Gabrielle-Perret-Gentil, 1211, Geneva 14, Switzerland.
Serge VulliemozDepartment of Neurology, University Hospitals and Medical School of Geneva, 4 rue Gabrielle-Perret-Gentil, 1211, Geneva 14, Switzerland.
Margitta SeeckDepartment of Neurology, University Hospitals and Medical School of Geneva, 4 rue Gabrielle-Perret-Gentil, 1211, Geneva 14, Switzerland.
Andrea O RossettiDepartment of Clinical Neurosciences, CHUV and University of Lausanne, Lausanne, Switzerland.
Fabienne PicardDepartment of Neurology, University Hospitals and Medical School of Geneva, 4 rue Gabrielle-Perret-Gentil, 1211, Geneva 14, Switzerland. Fabienne.Picard@hcuge.ch.
University Hospital of Geneva · CHClinique Valmont · CHInstitution de Lavigny · CHUniversity of Lausanne · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

There is little data concerning the prevalence of smoking in the population of people with epilepsy. The present study addresses this aspect in a sample of 429 unselected adults with epilepsy living in French-speaking Switzerland. The criterion of at least one cigarette per day for the past 6 months was used to define the status of "current" smoker. The questionnaires included questions about the type of epilepsy and tobacco consumption and were prospectively filled by attending neurologists in the presence of their patient, ensuring a reliable diagnosis of epilepsy. Data were compared with those of the "Tabakmonitoring" data collection, which gives annually detailed information about tobacco use habits in the Switzerland's population according to the different linguistic regions. Among patients suffering from epilepsy, the prevalence of current smoking was 32.1 % (28.8 % among women and 35 % among men), while the prevalence of smoking was 19.0 % in the general population in French-speaking Switzerland in the same period [OR 2.0, confidence interval (CI) 1.6-2.5, p < 0.001]. The subgroup of patients with epilepsy suffering from idiopathic (genetic) generalized epilepsy had the highest prevalence of smoking: 44.3 versus 27.8 % in the other types of epilepsy-p = 0.03. Epilepsy appears significantly correlated to smoking. The possible causal relationship, such as common genetic susceptibility to epilepsy and to nicotine addiction, indirect comorbidity through stress or depression associated with epilepsy, beneficial effect of nicotine on epilepsy, still remains unclear and deserves further studies.

Indexed as

AdolescentAdultAgedAge DistributionCross-Sectional StudiesEpilepsyFemaleHumansMaleMiddle AgedPrevalenceRetrospective StudiesSmokingSwitzerlandYoung AdultEpilepsyFrench-speaking SwitzerlandNicotinePrevalenceSmokingTobacco

Identifiers

PMID27416858
OpenAlexW2467989963

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.